Daiichi-Sankyo Type 2 treatment study (Colesevelam) for Pediatric Patients

• For individuals ages 10-17
• For those diagnosed with type 2 diabetes
• Additional eligibility criteria will be reviewed with you by the study coordinator

Novo Nordisk Type 2 Treatment (Liraglutide) Trial for Pediatric Patients

• For individuals ages 10-17
• Have been diagnosed with type 2 diabetes for at least 90 days
• Additional eligibility criteria will be reviewed with you by the study coordinator

If you would like to participate in a study or are interested in learning more about our research program, please complete this form and email it to us. A member of our team will contact you soon thereafter.

You may also call us at (813) 396-2595.